Summit Therapeutics Inc. Property, Plant and Equipment, Gross
Summit Therapeutics Inc. (SMMT) had Property, Plant and Equipment, Gross of $1.37 million as of 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-02-24
- 2024-12-31: Property, Plant and Equipment, Gross $1.37M.
- 2023-12-31: Property, Plant and Equipment, Gross $1.25M.
- 2022-12-31: Property, Plant and Equipment, Gross $2.20M.
- 2021-12-31: Property, Plant and Equipment, Gross $1.73M; Property, Plant and Equipment, Gross as first filed $4.07M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2024-12-31 | $1.37M 10-K · filed 2025-02-24 | |
| 2023-12-31 | $1.25M 10-K · filed 2025-02-24 | |
| 2022-12-31 | $2.20M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $1.73M 10-K · filed 2023-03-09 | $4.07M 10-K · filed 2022-03-17 |
| 2020-12-31 | $1.85M 10-K/A · filed 2022-12-21 | |
| 2019-12-31 | $1.54M 10-K · filed 2021-03-31 | |
| 2019-01-31 | $1.34M 8-K · filed 2020-09-29 | |
| 2018-01-31 | $1.38M 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |